87

Hematology&Oncology
Sub Categories on Hematology&Oncology
Latest Articles
Black patients diagnosed with aggressive leukemia experience worse outcomes

Black patients diagnosed with aggressive leukemia experience worse outcomes

byUniversity of Maryland School of MedicineCredit: Ninthgrid from PexelsCompared with white patients, Black patients with an aggressive form of leukemia—called acute myeloid leukemia (AML)—were on ave

Black patients diagnosed with aggressive leukemia experience worse outcomes

byUniversity of Maryland School of MedicineCredit: Ninthgrid from PexelsCompared with white patients, Black patients with an aggressive form of leukemia—called acute myeloid leukemia (AML)—were on ave
Blood test can detect single lung cancer calls using infrared technique

Blood test can detect single lung cancer calls using infrared technique

by Meg Cox,Loughborough UniversityThis figure shows how the technique identifies a single circulating tumor cell (CTC) in a lung cancer patient's blood sample. The sample is first viewed under a m

Blood test can detect single lung cancer calls using infrared technique

by Meg Cox,Loughborough UniversityThis figure shows how the technique identifies a single circulating tumor cell (CTC) in a lung cancer patient's blood sample. The sample is first viewed under a m
Accelerated cancer drug approvals yield modest survival gains at significant Medicare cost

Accelerated cancer drug approvals yield modest survival gains at significant Medicare cost

byHarvard Pilgrim Health Care InstituteCredit: Unsplash/CC0 Public DomainEarly access to new cancer drugs, granted accelerated approval by the U.S. Food and Drug Administration (FDA), has provided mix

Accelerated cancer drug approvals yield modest survival gains at significant Medicare cost

byHarvard Pilgrim Health Care InstituteCredit: Unsplash/CC0 Public DomainEarly access to new cancer drugs, granted accelerated approval by the U.S. Food and Drug Administration (FDA), has provided mix
30-year smoking duration-based criteria could increase lung cancer screening

30-year smoking duration-based criteria could increase lung cancer screening

by Elana GotkineThirty-year smoking duration-based criteria could reduce eligibility gaps for all races relative to whites, while improving six-year lung cancer detection sensitivity, according to a s

30-year smoking duration-based criteria could increase lung cancer screening

by Elana GotkineThirty-year smoking duration-based criteria could reduce eligibility gaps for all races relative to whites, while improving six-year lung cancer detection sensitivity, according to a s
Clinical trial of personalized cancer vaccine demonstrates feasibility, safety, immune activation

Clinical trial of personalized cancer vaccine demonstrates feasibility, safety, immune activation

byHarvard UniversityThe personalized biomaterial-based cancer vaccine consists of a porous biomaterial scaffold the size of an aspirin tablet that is infused with immune cell-recruiting and activating

Clinical trial of personalized cancer vaccine demonstrates feasibility, safety, immune activation

byHarvard UniversityThe personalized biomaterial-based cancer vaccine consists of a porous biomaterial scaffold the size of an aspirin tablet that is infused with immune cell-recruiting and activating
Doctors provide new hope for pancreatic cancer patients with less invasive radiofrequency ablation

Doctors provide new hope for pancreatic cancer patients with less invasive radiofrequency ablation

byUniversity of Texas at San AntonioCredit: Unsplash/CC0 Public DomainUT Health San Antonio Multispecialty and Research Hospital became the first in South Texas to use an emerging and less-invasive tr

Doctors provide new hope for pancreatic cancer patients with less invasive radiofrequency ablation

byUniversity of Texas at San AntonioCredit: Unsplash/CC0 Public DomainUT Health San Antonio Multispecialty and Research Hospital became the first in South Texas to use an emerging and less-invasive tr
Cancer's hidden 'safety switch': Silencing TAK1 gene could boost immunotherapy performance

Cancer's hidden 'safety switch': Silencing TAK1 gene could boost immunotherapy performance

byLa Trobe UniversityCredit: Pixabay/CC0 Public DomainAustralian researchers have discovered that the TAK1 gene helps cancer cells survive attack from the immune system, revealing a mechanism that may

Cancer's hidden 'safety switch': Silencing TAK1 gene could boost immunotherapy performance

byLa Trobe UniversityCredit: Pixabay/CC0 Public DomainAustralian researchers have discovered that the TAK1 gene helps cancer cells survive attack from the immune system, revealing a mechanism that may
Combination treatment may help cut lifelong ibrutinib for chronic lymphocytic leukemia patients

Combination treatment may help cut lifelong ibrutinib for chronic lymphocytic leukemia patients

byAmerican Association for Cancer ResearchCredit: Pixabay/CC0 Public DomainChronic lymphocytic leukemia (CLL) is the most prevalent adult leukemia in the Western Hemisphere, affecting approximately 20

Combination treatment may help cut lifelong ibrutinib for chronic lymphocytic leukemia patients

byAmerican Association for Cancer ResearchCredit: Pixabay/CC0 Public DomainChronic lymphocytic leukemia (CLL) is the most prevalent adult leukemia in the Western Hemisphere, affecting approximately 20
Population-based lung cancer screening can reduce mortality in people who have never smoked, study shows

Population-based lung cancer screening can reduce mortality in people who have never smoked, study shows

byEuropean Society for Medical OncologyCredit: Unsplash/CC0 Public DomainNew evidence from a Chinese cohort presented at theEuropean Lung Cancer Congress (ELCC) 2026shows that one-time low-dose comput

Population-based lung cancer screening can reduce mortality in people who have never smoked, study shows

byEuropean Society for Medical OncologyCredit: Unsplash/CC0 Public DomainNew evidence from a Chinese cohort presented at theEuropean Lung Cancer Congress (ELCC) 2026shows that one-time low-dose comput
Prioritizing potentially cancer-causing mutations in real-world cancer genomics

Prioritizing potentially cancer-causing mutations in real-world cancer genomics

byHiroshima UniversityOverview of a framework for prioritizing variants of uncertain significance (VUS) identified by comprehensive genomic profiling (CGP), based on real-world data from 2,172 tests s

Prioritizing potentially cancer-causing mutations in real-world cancer genomics

byHiroshima UniversityOverview of a framework for prioritizing variants of uncertain significance (VUS) identified by comprehensive genomic profiling (CGP), based on real-world data from 2,172 tests s
Early results from a trial of active surveillance for low-risk ductal carcinoma in situ are 'reassuring'

Early results from a trial of active surveillance for low-risk ductal carcinoma in situ are 'reassuring'

by European Organisation for Research and Treatment of CancerCredit: Unsplash/CC0 Public DomainResearchers leading a trial of active surveillance for ductal carcinoma in situ (DCIS) have described ear

Early results from a trial of active surveillance for low-risk ductal carcinoma in situ are 'reassuring'

by European Organisation for Research and Treatment of CancerCredit: Unsplash/CC0 Public DomainResearchers leading a trial of active surveillance for ductal carcinoma in situ (DCIS) have described ear
'Molecular glue' stabilizes protein that inhibits development of non-small cell lung cancer

'Molecular glue' stabilizes protein that inhibits development of non-small cell lung cancer

by Ananya Sen,University of MichiganCredit: Jacob Dwyer, Justine Ross, Michigan MedicineLung cancer is the second-most common cancer and the leading cause of cancer death in the United States. Over 80

'Molecular glue' stabilizes protein that inhibits development of non-small cell lung cancer

by Ananya Sen,University of MichiganCredit: Jacob Dwyer, Justine Ross, Michigan MedicineLung cancer is the second-most common cancer and the leading cause of cancer death in the United States. Over 80